Rapid answers, combined.

SARS-CoV-2 & Flu A/B Rapid Antigen Test

This test is a rapid chromatographic immunoassay for the qualitative detection of nucleocapsid protein antigens to SARS-CoV-2 virus and Influenza virus A and Influenza virus B present in human nasopharyngeal specimen.

Learn More

Featured

Roche’s response to the COVID-19 pandemic

Roche is deeply committed to supporting the global response to put an end to the COVID-19 pandemic.

SARS-CoV-2 Rapid Antigen Test

Learn how the SARS-CoV-2 Rapid Antigen Test works

SARS-CoV-2 Rapid Antigen Test

Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2

Elecsys^® Anti-SARS-CoV-2 S

Immunoassay for the quantitative determination of antibodies to the SARS-CoV-2 spike protein

Making an impact with value-based healthcare

With healthcare costs continuing to rise, traditional volume-based systems urgently need to be replaced with patient-centric, outcomes-focused value-based healthcare (VBHC).

Global Access Program - HIV

Join the leading provider of HIV viral load testing as it expands access to diagnostic testing for countries hardest hit by HIV.

Sepsis

Sepsis is a condition that can be caused by bacteria, fungi or viruses in the blood and is the result of the body’s response to infection.

...

ASPIRE Point of Care Webinars

To engage, learn and inspire we have organized a series of webinars with speakers from all across the globe, sharing their thoughts and experiences on POCT.

View now

Join us

EuroMedLab 2022 - April 10-14

Witness the future of innovation in diagnostics.

Did you miss us at EuroMedLab 2022? Do not worry because you can still visit our virtual booth for the next 3 months (July 2022) to access all of our amazing content!

View now

Visit our virtual booth

Latest news

...

Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases

About Roche Diagnostics